Outcome for Patients Who Relapse After Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia

Abstract

We studied the clinical course of 130 chronic myeloid leukemia (CML) patients (89 males and 41 females) in the European Bone Marrow Transplantation Group (EBMT) registry who received transplants before January 1, 1988 and who subsequently had evidence of recurrent leukemia. All patients had received a pretransplant conditioning regimen including total body… (More)

Topics

10 Figures and Tables

Cite this paper

@inproceedings{Ljungman2003OutcomeFP, title={Outcome for Patients Who Relapse After Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia}, author={P Ljungman and Augustin Ferrant and Sayer and Dieter Niederwieser and Arnold and Giacomino Bandini}, year={2003} }